Manufacturers Life Insurance Company, The Fibrogen Inc Transaction History

Manufacturers Life Insurance Company, The

  • $103 Billion
  • Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Fibrogen Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 30,246 shares of FGEN stock, worth $26,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,246
Holding current value
$26,918
% of portfolio
0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$0.73 - $2.73 $22,079 - $82,571
30,246 New
30,246 $71,000
Q2 2023

Aug 11, 2023
SELL
$2.49 - $20.59 $100,663 - $832,391
-40,427 Reduced 52.29%
36,880 $99,000
Q1 2023

May 15, 2023
SELL
$15.95 - $25.18 $322,652 - $509,366
-20,229 Reduced 26.17%
57,078 $1.07 Million
Q4 2022

Aug 11, 2023
BUY
$13.27 - $17.73 $556,384 - $743,383
41,928 Added 118.51%
77,307 $1.24 Million
Q4 2022

Feb 13, 2023
BUY
$13.27 - $17.73 $556,384 - $743,383
41,928 Added 118.51%
77,307 $1.24 Million
Q3 2022

Aug 11, 2023
SELL
$11.4 - $14.6 $9,439 - $12,088
-828 Reduced 2.29%
35,379 $460,000
Q3 2022

Nov 03, 2022
SELL
$11.4 - $14.6 $9,439 - $12,088
-828 Reduced 2.29%
35,379 $460,000
Q2 2022

Aug 11, 2023
SELL
$7.94 - $12.96 $1,746 - $2,851
-220 Reduced 0.6%
36,207 $382,000
Q2 2022

Aug 15, 2022
SELL
$7.94 - $12.96 $1,746 - $2,851
-220 Reduced 0.6%
36,207 $382,000
Q1 2022

Aug 11, 2023
SELL
$12.02 - $16.79 $248,225 - $346,730
-20,651 Reduced 36.18%
36,427 $437,000
Q1 2022

May 20, 2022
SELL
$12.02 - $16.79 $101,508 - $141,791
-8,445 Reduced 18.82%
36,427 $438,000
Q4 2021

Feb 16, 2022
SELL
$9.93 - $15.39 $10,615 - $16,451
-1,069 Reduced 2.33%
44,872 $633,000
Q3 2021

Nov 12, 2021
SELL
$10.18 - $26.64 $28,707 - $75,124
-2,820 Reduced 5.78%
45,941 $470,000
Q2 2021

Aug 12, 2021
BUY
$18.57 - $35.68 $21,596 - $41,495
1,163 Added 2.44%
48,761 $1.3 Million
Q1 2021

May 03, 2021
SELL
$31.0 - $55.72 $89,776 - $161,365
-2,896 Reduced 5.74%
47,598 $1.65 Million
Q4 2020

Feb 12, 2021
BUY
$37.09 - $48.97 $67,095 - $88,586
1,809 Added 3.72%
50,494 $1.87 Million
Q3 2020

Nov 09, 2020
SELL
$40.47 - $45.5 $31,607 - $35,535
-781 Reduced 1.58%
48,685 $2 Million
Q2 2020

Aug 10, 2020
SELL
$32.57 - $42.83 $16,252 - $21,372
-499 Reduced 1.0%
49,466 $2.01 Million
Q1 2020

May 15, 2020
BUY
$23.3 - $45.96 $76,191 - $150,289
3,270 Added 7.0%
49,965 $1.74 Million
Q4 2019

Feb 14, 2020
SELL
$34.58 - $48.06 $49,103 - $68,245
-1,420 Reduced 2.95%
46,695 $2 Million
Q3 2019

Nov 12, 2019
SELL
$36.98 - $48.45 $12,610 - $16,521
-341 Reduced 0.7%
48,115 $1.82 Million
Q2 2019

Aug 14, 2019
SELL
$35.13 - $55.53 $46,231 - $73,077
-1,316 Reduced 2.64%
48,456 $2.19 Million
Q1 2019

May 13, 2019
SELL
$42.83 - $59.91 $74,695 - $104,483
-1,744 Reduced 3.39%
49,772 $2.71 Million
Q4 2018

Feb 14, 2019
BUY
$37.97 - $60.16 $111,479 - $176,629
2,936 Added 6.04%
51,516 $2.38 Million
Q3 2018

Nov 14, 2018
SELL
$56.3 - $67.25 $383,515 - $458,107
-6,812 Reduced 12.3%
48,580 $2.95 Million
Q2 2018

Aug 14, 2018
BUY
$44.9 - $64.95 $150,908 - $218,296
3,361 Added 6.46%
55,392 $3.47 Million
Q1 2018

May 15, 2018
SELL
$45.35 - $61.65 $52,878 - $71,883
-1,166 Reduced 2.19%
52,031 $2.4 Million
Q4 2017

Feb 08, 2018
BUY
$41.95 - $60.1 $120,480 - $172,607
2,872 Added 5.71%
53,197 $2.52 Million
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $1.68 Million - $2.71 Million
50,325
50,325 $2.71 Million

Others Institutions Holding FGEN

# of Institutions
120
Shares Held
62.2M
Call Options Held
1.54M
Put Options Held
221K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $83.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email